60 Degrees Pharmaceuticals (SXTP) executive compensation, 2025 proxy

Geoffrey Dow, President and Chief Executive Officer, was paid $323,425 in 2024, up 158% from $125,555 the year before.

Filed
August 27, 2025
Annual meeting
October 8, 2025
Pay year
2024
Named executives
3
CEO total pay
$323,425+158% vs prior year
CEO pay in equity
23%$75,425 in awards
CFO total compensation
$284,525
CCO total compensation
$470,862
CCO cash bonus
$113,570
CEO stock bonus
$24,175
CEO option award
$51,250

How Dow was paid

$323,425 in total for 2024, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary70%Bonus6%Stock awards7%Option awards16%

Named executive officers

ExecutiveTotal
Geoffrey DowPresident and Chief Executive Officer$323,425
Tyrone MillerChief Financial Officer$284,525
Kristen LandonChief Commercial Officer$470,862

What changed and why

  • $323K$323,425 was Geoffrey Dow's 2024 total compensation, compared with $125,555 in 2023.
  • $51,250$51,250 of Dow's 2024 compensation came from option awards, and $24,175 came from stock bonuses.
  • $471K$470,862 was Kristen Landon's 2024 total compensation, including a $113,570 cash bonus.
  • $250K$250,000 was Dow's approved base salary for fiscal 2025, up from $228,000 in 2024.
  • $215K$215,000 was Miller's approved base salary for fiscal 2025, up from $204,000 in 2024.
  • 120,000 options were granted to Dow and Miller in January 2025 as long-term incentive awards.

Other 60 Degrees Pharmaceuticals proxy statements

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.